AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2021

May 21, 2021

33298_dirs_2021-05-21_c2d32989-b0bb-43bd-846e-0bac8adc4eae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-05-19

Reporting Person: Galluppi Stefan (Director, Chief Technology Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-19	Common Stock, par value $0.01	P	3796	$10.4	Acquired	3796	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	1649800	Indirect

Footnotes

F1: An audit of the reporting person's indirect holdings resulted in a slight adjustment in shares beneficially owned. The holdings reported on this Form 4 are the correct amount of indirectly held securities beneficially owned.